 |
|
|
|
|
| First Name: | Ralf | | Last Name: | Ihl | | Title: | Prof. Dr. | | Affiliation: | Alexian Hospital | | Department: | Geriatric Psychiatry | | Street Address 1: | Oberdiessemer Str. 136 | | City: | Krefeld | | State/Province: | NRW | | Zip/Postal Code: | D-47805 | Country/Territory: | Germany | | Phone: | 2151347904 | | Fax: | 2151347901 | | Email Address: |  |
Disclosure:
(view policy) |
Member reports the following financial or other potential conflicts of interest: [Last Modified: 28 November 2008]
2005-2008
Funding
Research support:Deutsche Alzheimer Stiftung, Kompetenznetz Demenzen des Bundesministeriums für Bildung und Forschung;
Employment
Alexian Hospital, Krefeld;Consulting and Advisory boards honoraria:Dendrite, GE Healthcare, Gerson Lehrman Group, IFE, Infobüro, Merz, rapidata, Synthon BV; Speakers honoraria:
Austroplant, Barmer Ersatzkasse, Eisai, Institut für Kirche und Gesellschaft, Knappschaftskrankenhaus Recklinghausen, LV Rheinland, Lebenswerk, Lundbeck, Merz, Novartis, Schwabe, Stadt Dortmund, Caritas Akademie, Universität Bonn, Universität Bochum;Royalties:
Beltz Test, BOD, Hogrefe, Med. Komm., Thieme, Urban & Vogel, Westermayer
Personal financial interests: None
|
|
|
View all comments by Ralf Ihl
|
Alzheimer Disease, Aging Process
|
Diagnosis, Clinical trials
|
Academic Background
Year Degree Place
1983 Diploma in Psychology U Mainz
1985 Licensure U Mainz
1986 Medical doctor U Wuerzburg
1991 Doctor of Neuropsychiatry Bayerische Landesärztekammer
1997 Priv.-Doc. U Duesseldorf
2002 Professor of PsychiatryU Duesseldorf
Professional Experience
1983 – 1993 Department of Psychiatry, University of Wuerzburg, Psychiatrist
1993 - 2005 Department of Psychiatry, University of Duesseldorf, Head of the Laboratory of Neurophysiology and Psychophysiology
Vice-chair of the Department of Geriatric Psychiatry
2005 – present Alexian Hospital Cologne, head of department
2007 - present Alexian Hospital Krefeld, head of department
Professional Society Memberships
Board Memberships
Since 1988 International Society for Neuroimaging in Psychiatry Board of directors (Secretary and founding member)
10/1992-11/1997 German Alzheimer Association
Vice-president and founding member
Since 1998 German Brain League Board of directors (Secretary)
Since 2004 European Association of Geriatric Psychiatry President |
Ihl R, Frölich L, Dierks T, Martin EM, Maurer K. Differential validity of psychometric tests in dementia of the Alzheimer type. Psychiatry Res. 1992 Nov;44(2):93-106. PMID: 1480682
Ihl R, Dierks T, Martin EM, Froölich L, Maurer K.Topography of the maximum of the amplitude of EEG frequency bands in dementia of the Alzheimer type. Biol Psychiatry. 1996 Mar 1;39(5):319-25.
PMID: 8704062
Prior R, D'Urso D, Frank R, Prikulis I, Cleven S, Ihl R, Pavlakovic G.Selective binding of soluble Abeta1-40 and Abeta1-42 to a subset of senile plaques. Am J Pathol. 1996 Jun;148(6):1749-56. PMID: 8669461
Ihl R, Brinkmeyer J. Differential diagnosis of aging, dementia of the Alzheimer type and depression with EEG-segmentation. Dement Geriatr Cogn Disord. 1999 Mar-Apr;10(2):64-9. PMID: 10026377
Ihl R, Grass-Kapanke B, Jänner M, Weyer G. Neuropsychometric tests in cross sectional and longitudinal studies - a regression analysis of ADAS - cog, SKT and MMSE. Pharmacopsychiatry. 1999 Nov;32(6):248-54. PMID: 10599935
Streit M, Wölwer W, Brinkmeyer J, Ihl R, Gaebel W.Electrophysiological correlates of emotional and structural face processing in humans. Neurosci Lett. 2000 Jan 7;278(1-2):13-6. PMID: 10643789
Ihl R, Brinkmeyer J, Jänner M, Kerdar MS.
A comparison of ADAS and EEG in the discrimination of patients with dementia of the Alzheimer type from healthy controls. Neuropsychobiology. 2000 Jan;41(2):102-7. PMID: 10644931
Streit M, Wölwer W, Brinkmeyer J, Ihl R, Gaebel W. EEG-correlates of facial affect recognition and categorisation of blurred faces in schizophrenic patients and healthy volunteers.
Schizophr Res. 2001 Apr 15;49(1-2):145-55. PMID: 11343873
Brinkmeyer J, Grass-Kapanke B, Ihl R.EEG and the Test for the Early Detection of Dementia with Discrimination from Depression (TE4D): a validation study.Int J Geriatr Psychiatry. 2004 Aug;19(8):749-53.PMID: 15290698
Mesbah M, Grass-Kapanke B, Ihl R.Treatment Target Test Dementia (3TD) (c). Int J Geriatr Psychiatry. 2008 Dec;23(12):1239-44. PMID: 18537199
|
To insist on the amyloid hypothesis. |
Ginkgo biloba for prevention of dementia: a randomized controlled trial. DeKosky ST, Williamson JD, Fitzpatrick AL, Kronmal RA, Ives DG, Saxton JA, Lopez OL, Burke G, Carlson MC, Fried LP, Kuller LH, Robbins JA, Tracy RP, Woolard NF, Dunn L, Snitz BE, Nahin RL, Furberg CD; Ginkgo Evaluation of Memory (GEM) Study Investigators. JAMA. 2008 Nov 19;300(19):2253-62.
PMID: 19017911
|
Investigate the cause of cell death in Alzheimers. Improve the drug treamtent of neuropsychiatric symptoms. Optimize the mehtodology of non-pharamceutical treatment studies. |
A metabolic defect causes Alzheimers. |
Will depend on what is falsified. |
|
|
|
|
|
Home
